Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 19 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

2 trials in Phase 3/4

Results Transparency

0%

0 of 17 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 1
13(68.4%)
Phase 2
3(15.8%)
Phase 3
2(10.5%)
N/A
1(5.3%)
19Total
Phase 1(13)
Phase 2(3)
Phase 3(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (19)

Showing 19 of 19 trials
NCT07307794Phase 1Recruiting

To Evaluate the Adhesion of TK-254RX on Healthy Participants

Role: collaborator

NCT06866613Phase 3Completed

Phase III Trial to Evaluate the Efficacy and Safety in Patients With Ankle Sprains.

Role: collaborator

NCT06871046Phase 3Completed

Phase III Trial to Assess the Safety and Efficacy of TK-254RX in Patients With Contusions

Role: collaborator

NCT06870422Phase 1Completed

To Assess the Effect of the Special Condition on the Pharmacokinetics and Tolerability of the Esflurbiprofen Topical System (EFTS) in Healthy Volunteers.

Role: collaborator

NCT06823284Phase 1Completed

To Assess the Bioavailability of TK-254RX in Comparison with Oral Flurbiprofen Tablets and the Adhesion of TK-254RX in Healthy Subjects

Role: collaborator

NCT06097533Phase 2Recruiting

Improvement of Quality of Life by Cannabinoids in Oncologic Patients

Role: collaborator

NCT06247410Phase 2Completed

Clinical Trial to Investigate Patch Adhesion of Rotigotine Containing Patches in Patients With Parkinson's Disease

Role: collaborator

NCT06042192Phase 1Completed

Open Label Trial to Evaluate the Adhesion of TK-254RX in Healthy Volunteers.

Role: collaborator

NCT05853341Phase 1Completed

Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (13.3mg/24h)

Role: collaborator

NCT04790136Phase 1Completed

Cannabidiol Bioavailability Trial With Oral Multiple Dose Administration

Role: collaborator

NCT04505787Phase 1Completed

S-flurbiprofen Bioavailability Trial to Compare a Newly Developed Patch vs. a Marketed Tablet

Role: collaborator

NCT03659435Phase 1Completed

Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (9.5mg/24h)

Role: collaborator

NCT02686788Phase 2Completed

TMP001 in Relapsing-remitting Multiple Sclerosis

Role: collaborator

NCT03573050Phase 1Completed

Rivastigmine BA Trial With Multiple Application of Transdermal Patches, Adaptation and Tapering Phase

Role: collaborator

NCT03018015Phase 1Completed

Ibuprofen Bioavailability Trial With Oral Single Dose Administration.

Role: collaborator

NCT02980458Phase 1Completed

Characterisation of Relative Bioavailability With Bioequivalence Assessment of Deferiprone Tablets After Oral Single Dose Administration

Role: collaborator

NCT01333930Not ApplicableCompleted

Placebo Controlled Study for Characterisation of Immunological Effects and Safety of Active O2

Role: collaborator

NCT00884442Phase 1Completed

Nifedipine Bioavailability Study With Oral Single Doses Under Fasting and Fed Conditions

Role: collaborator

NCT00889850Phase 1Completed

Esomeprazole Bioavailability Study With 40 mg Oral Single Dose Fasted and Fed Administration

Role: collaborator

All 19 trials loaded